Attention-deficit/hyperactivity disorder
- PMID: 38388701
- DOI: 10.1038/s41572-024-00495-0
Attention-deficit/hyperactivity disorder
Erratum in
-
Author Correction: Attention-deficit/hyperactivity disorder.Nat Rev Dis Primers. 2024 Apr 15;10(1):29. doi: 10.1038/s41572-024-00518-w. Nat Rev Dis Primers. 2024. PMID: 38622144 No abstract available.
Abstract
Attention-deficit/hyperactivity disorder (ADHD; also known as hyperkinetic disorder) is a common neurodevelopmental condition that affects children and adults worldwide. ADHD has a predominantly genetic aetiology that involves common and rare genetic variants. Some environmental correlates of the disorder have been discovered but causation has been difficult to establish. The heterogeneity of the condition is evident in the diverse presentation of symptoms and levels of impairment, the numerous co-occurring mental and physical conditions, the various domains of neurocognitive impairment, and extensive minor structural and functional brain differences. The diagnosis of ADHD is reliable and valid when evaluated with standard diagnostic criteria. Curative treatments for ADHD do not exist but evidence-based treatments substantially reduce symptoms and/or functional impairment. Medications are effective for core symptoms and are usually well tolerated. Some non-pharmacological treatments are valuable, especially for improving adaptive functioning. Clinical and neurobiological research is ongoing and could lead to the creation of personalized diagnostic and therapeutic approaches for this disorder.
© 2024. Springer Nature Limited.
References
-
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders 5th edn (American Psychiatric Publishing, 2013).
-
- World Health Organization. International classification of diseases 11th revision (WHO, 2022).
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical